Silco Pharmaceuticals reported a fall in profitability for the financial year ended June, with its stock exchange filing showing annual Earnings Per Share dropping to Tk0.41 from Tk0.44 a year earlier.
The company’s Net Asset Value per share, however, rose to Tk23.02 from Tk22.66, although its net operating cash flow per share weakened to Tk0.74 from Tk0.81, indicating softer cash generation despite the improvement in asset value.
In line with its performance, the board recommended a 1.10% cash dividend for the year, while directors opted not to take the dividend.
Silco said directors collectively hold 36,615,370 shares out of 103,807,000 shares, meaning the declared Tk7,391,079 dividend will be distributed among the remaining shareholders who own 67,191,630 shares.
The company also announced that its Annual General Meeting will be held on 19 January 2026 in a hybrid format, allowing both online participation and physical attendance at the registered office premises.
The record date has been set for 15 December, and shareholders holding Silco shares on that day will qualify for AGM participation and dividends.
On the market front, Silco shares closed 3.17% higher at Tk13 on the Dhaka Stock Exchange on Tuesday.
